A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples